• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Increasing Obesity Levels and High Genetic Vulnerability Driving the Prevalence of Diabetes in India
 

Increasing Obesity Levels and High Genetic Vulnerability Driving the Prevalence of Diabetes in India

on

  • 161 views

As a result of a higher percentage of body fat to muscle, Indians are more vulnerable to type-2 diabetes compared to other population groups.

As a result of a higher percentage of body fat to muscle, Indians are more vulnerable to type-2 diabetes compared to other population groups.

Statistics

Views

Total Views
161
Views on SlideShare
161
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Increasing Obesity Levels and High Genetic Vulnerability Driving the Prevalence of Diabetes in India Increasing Obesity Levels and High Genetic Vulnerability Driving the Prevalence of Diabetes in India Document Transcript

    • Increasing Obesity Levels and High Genetic Vulnerability Driving the Prevalence of Diabetes in IndiaAs a result of a higher percentage of body fat to muscle, Indians are more vulnerable totype-2 diabetes compared to other population groups.IMARC Group, one of the world’s leading research and advisory firms, finds that the totalnumber of diabetes patients in India grew at CAGR of nearly 3% during 2004 - 2012.Estimates from their latest report entitled “Indian Diabetes Market Report: Epidemiology,Patients, Prevalence, Oral Anti-diabetics, Insulin and Diagnostics”, suggests that thetotal number of diabetes patients in India is expected to reach 107 million by 2032.Findings from the report suggest that a major driver of the diabetes epidemic in India is theincreasing levels of obesity. The Indian population that had faced under nutrition for a longtime is now exposed to high fat diets and sedentary lifestyles. As a result of increasingdisposable incomes and flourishing fast food chains, there were around 157 millionoverweight and 24 million obese people living in India in 2010. The report expects theselevels to increase significantly by 2015.Apart from the increasing obesity levels, the report also found that Indians are geneticallymore vulnerable to diabetes compared to other population groups. According to an analyst atIMARC Group “As a result of a higher percentage of body fat to muscle, Indians are morevulnerable to type-2 diabetes compared to other population groups. This fat increases thesugar levels as it gets deposited around the abdomen and interferes with insulin. As a result,Indians get diabetes at a much younger age compared to other population groups”.IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients,Prevalence, Oral Anti-diabetics, Insulin and Diagnostics” provides an analytical andstatistical insight into the Indian diabetes market. The report provides both current and futuretrends in the prevalence, demographical breakup, diagnosis and treatment of diabetes inIndia. The report has segmented the Indian diabetes market into three segments - Oral Anti-diabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, thereport provides historical and future market sales, performance of key classes and theperformance of top players.The research study serves as an exceptional tool to understand the epidemiology, markettrends, therapeutic structure, competitive structure and the outlook of the Indian diabetes
    • market. This report can serve as an excellent guide for investors, researchers, consultants,marketing strategists and all those who are planning to foray into the Indian diabetes marketin some form or the other.To buy the complete report or to get a free sample, please contact:IMARC Group AsiaEmail: apac@imarcgroup.comPhone: +91-120-415-5099IMARC Group North AmericaEmail: america@imarcgroup.comPhone: +1-631-791-1145IMARC Group Europe, Middle East & AfricaEmail:ema@imarcgroup.comPhone: +44-702-409-7331To know more please visit: http://www.imarcgroup.com/indian-diabetes-market-report-epidemiology-patients-prevalence-oral-anti-diabetics-insulin-and-diagnostics/